Target intelligence / Profile preview

Gamma-glutamyltransferase 4 pseudogene (GGT4P)

Target: GGT4P
Molecular classification: Pseudogene

Overview

Gamma-glutamyltransferase 4 pseudogene (GGT4P) is a genomically annotated pseudogene derived from gamma-glutamyltransferase family sequences. It is located in a gene segment on chromosome 13 alongside FAM230C and LOC101060145 and does not encode a functional protein product. The establishment of GGT4P is linked to chromosomal segmental duplications and the broader evolution of non-coding RNA genes and other GGT-derived pseudogenes. Unlike active members of the GGT family (e.g., GGT1, GGT5), GGT4P does not have known enzymatic activity, biological function, or disease relevance[1].

Mechanism of action

None

Biological functions

None known

Disease associations

None known

Beyond the preview

Go deeper on Gamma-glutamyltransferase 4 pseudogene (GGT4P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-glutamyltransferase 4 pseudogene (GGT4P).

Explore the full profile